Immune checkpoint inhibitor-related colitis assessment and prognosis: can IBD scoring point the way?
<p><strong>Background</strong> Immune checkpoint inhibitors (ICI) improve survival but cause immune-related adverse events (irAE). We sought to determine if CTCAE classification, IBD biomarkers/endoscopic/histological scores correlate with irAE colitis outcomes.</p> <p>...
| Autori principali: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Natura: | Journal article |
| Lingua: | English |
| Pubblicazione: |
Springer Nature
2020
|